In response to the COVID-19 pandemic, Moss Inc. has expanded its global manufacturing capabilities to include high-speed automated production for Personal Protective Equipment. Moss’s new fleet of proprietary manufacturing technology can produce a total global output of 1.2 Million face masks per day.

The automated manufacturing system was developed in collaboration with the Fraunhofer Institute of Product Technology IPT and a local machine builder in Germany. Moss will scale capacity in Europe and North America to produce a global output of 3 Million masks a week by June and reach 6 Million masks per week by August. The masks are developed to meet the EN14683 surgical MNS mask standard in Germany and the ASTM Level 2 Procedure Mask rating in North America.


In planning the plant, the partners considered the entire supply chain from the production of the required materials to certification and supply chain management. As soon as the first prototype is completed, it will be optimized further by Fraunhofer IPT in order to scale and automate the production of the face masks.

“Textiles and stitching have been a part of the Moss legacy since the 1950s. We’re proud to take these new production steps to help fight the COVID-19 pandemic and to secure ample, competitively-priced supply for global public health needs,” said Dan Patterson, President & CEO of Moss.

“Because of these skills in textile processing, we received many inquiries on whether we could help with face masks, including inquiries for hundreds of thousands,” said Peter Bottenberg, Managing Director of Moss Germany. “Thinking in solutions instead of problems has always been Moss’s greatest strength, and we’re grateful for the dynamic partners who undertook a quick solution with us.”


Leveraging its global network of suppliers, Moss supply chain experts continue to secure needed materials and confirm that suppliers meet Moss’s standards of excellence for reliable, quality fulfilment.

While Moss has already shipped several large mask orders, it will soon have the capacity to fulfil high-volume orders from governments and public health organizations, including national contracts and re-stockpiling. Information is available at